Research and innovation from the nephrology experts at Vanderbilt Health
Empagliflozin Beneficial in Early-Stage Heart Failure Cases
Multinational trial demonstrates short- and long-term benefits of the SGLT2 inhibitor for hospitalized patients.Read More
Latest in Nephrology
Creating the First Implantable Bioartificial Kidney
Part 1: From Concept to Preclinical Trials
Magnesium Depletion Score Highlights Risk Factors
A new estimating tool may more accurately identify deficiencies associated with serious health risks.
Researchers Examine Risks of Necrotizing Enterocolitis in Premature Infants
In-depth characterization of necrotizing enterocolitis yields new data on the burden of sepsis and how to predict those at highest risk.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.Make a Referral
Ileovesicostomy for Refractory Bladder in Children
Some patients gain stable or superior renal and urologic function compared with augmentation cystoplasty.
Seeking Drivers for Clear Cell Renal Cell Carcinoma
Clinical trial to test RNA sequencing for matching appropriate treatments to specific tumors.
Block this Receptor to Derail Kidney Fibrosis
New study details pathways promoting kidney inflammation and fibrosis, raising new concepts for treatment.
Studies Examine Viral Risks in Kidney Transplantation from HCV+ Donors
National research initiatives explore infection risk, timing of DAAs and other treatment factors.
Robotic-assisted, Living-donor Nephrectomy is New Standard
Tech offers an improved transplant experience for donors, recipients and surgeons.
Vein Arterialization Is Saving ‘Desert Feet’
A percutaneous procedure to avert amputation in patients with chronic limb-threatening ischemia.